QUEST DIAGNOSTICS INC 4

SVP Patrick Plewman acquired 46 shares of Quest Diagnostics Inc. common stock via a dividend reinvestment plan.

On July 22, 2026, Patrick Plewman, SVP for Diagnostic Services at Quest Diagnostics Inc., acquired 46 shares of the company’s common stock at an average price of approximately $206.81 per share through a broker-administered dividend reinvestment plan, a routine and typically low-signal form of insider acquisition that is technically eligible for deferred reporting on Form 5 but was voluntarily reported early on this Form 4. Following this small, automatic reinvestment transaction, Plewman beneficially owns 15,293 shares of Quest Diagnostics common stock, representing a holding worth roughly $3.5 million at the current market price, indicating that the transaction is immaterial in size relative to his existing equity stake and appears to be standard compensation- and dividend-related activity rather than a discretionary open-market trade.

Filing Facts

CIK

1022079

Ticker

DGX

Form

4

Source Type

sec

Accession

0001022079-26-000083

Alert Tier

6